Valuation: DiaSorin S.p.A.

Market Cap 3.73B 4.31B 3.49B 3.2B 6.01B 411B 6.11B 40.89B 16.05B 206B 16.2B 15.85B 680B P/E 2026 *
21.7x
P/E 2027 * 19.1x
Enterprise Value 4.43B 5.12B 4.14B 3.79B 7.14B 487B 7.25B 48.53B 19.05B 244B 19.23B 18.81B 808B EV / Sales 2026 *
3.59x
EV / Sales 2027 * 3.26x
Free-Float
37.17%
Yield 2026 *
1.73%
Yield 2027 * 1.82%
1 day+1.26%
1 week+4.93%
Current month+4.93%
1 month+13.25%
3 months+19.30%
6 months+2.61%
Current year+9.88%
1 week 72.36
Extreme 72.36
76.46
1 month 63
Extreme 63
76.46
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap.
1/28/26 A Buy

Chief Executive Officer

7,500 0.0134%
1/8/26 A Buy

Director

700 0.0013%
1/8/26 A Buy

Director

1,000 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
+1.26%+4.93%-9.05%-19.79% 4.31B
+6.92%+4.01%+210.68%+357.33% 22.61B
+0.48%+5.43%-41.58%-22.48% 9.91B
+14.10%+10.07%+323.35%-4.00% 6.78B
-0.12%+1.31%+76.49%+43.37% 6.59B
+13.70%+45.12%-23.56% - 6.43B
+2.88%+0.88%-12.31%-12.66% 5.62B
+1.75%+6.08%+83.15%+104.62% 4.51B
+1.31%-2.05%-20.81%-36.85% 2.75B
+7.63%+4.03%-53.86%+182.82% 1.46B
Average +4.99%+8.43%+53.25%+65.82% 7.1B
Weighted average by Cap. +5.47%+8.26%+99.01%+133.18%

Financials

2026 *2027 *
Net sales 1.23B 1.43B 1.15B 1.06B 1.99B 136B 2.02B 13.52B 5.31B 68.07B 5.36B 5.24B 225B 1.31B 1.52B 1.22B 1.12B 2.11B 144B 2.15B 14.36B 5.64B 72.28B 5.69B 5.57B 239B
Net income 181M 209M 169M 155M 291M 19.86B 296M 1.98B 776M 9.96B 784M 767M 32.92B 205M 238M 192M 176M 331M 22.61B 336M 2.25B 884M 11.33B 892M 873M 37.47B
Net Debt 697M 806M 651M 597M 1.12B 76.72B 1.14B 7.64B 3B 38.45B 3.03B 2.96B 127B 539M 623M 503M 462M 868M 59.28B 882M 5.9B 2.32B 29.71B 2.34B 2.29B 98.23B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,260
Date Price Change Volume
07/08/26 €75.40 +1.26% 251,852
06/08/26 €74.46 -0.61% 118,192
05/08/26 €74.92 +0.56% 132,598
04/08/26 €74.50 -0.88% 191,765
03/08/26 €75.16 +4.59% 567,451
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
75.40EUR
Average target price
72.45EUR
Spread / Average Target
-3.91%

Quarterly revenue - Rate of surprise